News & Analysis as of

Food and Drug Administration (FDA) Government Agencies Environmental Protection Agency (EPA)

Akin Gump Strauss Hauer & Feld LLP

The Trump Administration Seeks to Spur Domestic Drug Manufacturing with Regulatory Relief EO

On May 5, President Trump issued an Executive Order (EO) titled “Regulatory Relief to Promote Domestic Production of Critical Medicines,” with the stated purpose of eliminating “regulatory barriers to the domestic production...more

Hogan Lovells

President Trump Establishes the Make America Healthy Again Commission

Hogan Lovells on

Yesterday, the Senate confirmed Robert F. Kennedy, Jr. as the Secretary of the Department of Health and Human Services (HHS). Shortly after his confirmation, President Trump issued an Executive Order establishing the Make...more

Holland & Knight LLP

What's Next for the Regulatory Landscape Post-Chevron?

Holland & Knight LLP on

For nearly 40 years and in more than 18,000 judicial opinions, federal courts have used the Chevron doctrine to defer to an agency's reasonable interpretation of an ambiguous statute. On June 28, 2024, the U.S. Supreme Court...more

Sullivan & Worcester

PFAS Updates: Congressional and Federal Regulatory Developments

Sullivan & Worcester on

This posting provides an update on PFAS developments involving federal legislative and regulatory activities. Congress - On November 6, 2019, a panel of experts at a congressional briefing sponsored by the Endocrine...more

4 Results
 / 
View per page
Page: of 1

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide